Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Post Traumatic Stress Disorder
Biotech
With MDMA debate spreading, Lykos CEO tries to dispel concerns
A week after an FDA committee declined to support an MDMA treatment for PTSD, Lykos Therapeutics CEO Amy Emerson is trying to dispel concerns.
Annalee Armstrong
Jun 13, 2024 10:22am
Lykos' MDMA treatment rejected by FDA committee
Jun 5, 2024 10:20am
Jazz drops PTSD drug over phase 2 trial failure
Dec 22, 2023 5:21am
FDA clears 1st neuromodulation device for PTSD treatment
Mar 24, 2023 10:50am
Study: Sleep wearable could reduce PTSD risk
Aug 17, 2016 10:28am
